14/03/2019 17:03:00

Director/PDMR Shareholding

BlackRock Greater Europe Investment Trust Plc - Director/PDMR Shareholding

PR Newswire

BlackRock Greater Europe Investment Trust plc

LEI - 5493003R8FJ6I76ZUW55

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with the

m

1

Deta

ils  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

a)NamePaola Subacchi

2

Reaso

n for the notification

a)Position/statusNon-Executive Director
b)Initial notification/AmendmentInitial notification

3

Deta

ils of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)NameBlackRock Greater Europe Investment Trust plc
b)LEI5493003R8FJ6I76ZUW55

4

Deta

ils of the transaction(s): section to be repeated for (i) each type of instrument;

(ii

) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.1p each (shares)

GB00B01RDH75

b)Nature of the transactionPurchase of Shares
c)Price(s) and volume(s)

Price(s)Volume(s)
329p590

d)

Aggregated information

- Aggregated volume

- Price

 

  n/a (single transaction - see above)

e)

Date of the transaction

2019-03-14

f)

Place of the transaction

London Stock Exchange (XLON)

Related content
21 Aug - 
Net Asset Value(s)
21 Aug - 
Portfolio Update
20 Aug - 
Net Asset Value(s)
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

21 Aug E:BRGE
21 Aug E:BRGE
20 Aug E:BRGE
19 Aug E:BRGE
16 Aug E:BRGE
15 Aug E:BRGE
14 Aug E:BRGE
13 Aug E:BRGE
12 Aug E:BRGE
09 Aug E:BRGE

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock
2
MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
3
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
4
Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan
5
Ambu A/S: Interim report for Q3 2018/19

Related stock quotes


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
22 August 2019 08:45:02
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB2 - 2019-08-22 09:45:02 - 2019-08-22 08:45:02 - 1000 - Website: OKAY